Live Quote · NASDAQIMMXHealthcare· Biotechnology

Immix Biopharma, Inc.

$6.96▼ 1.14%($-0.08)
MKT CAP $583.33MNEXT EARNINGS Mar 24, 2027
50%
Bullish
TickerSpark Score
47/100
▌ Weak
87
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMMX research report →

Analyst Price Target
$22.67+225.7% vs. today

Range $20 – $25

Analyst RatingBuy
6 Buy0 Hold0 Sell

Price Chart

+73.13% · this period
$14.47$9.22$3.97Nov 20May 26Nov 20
52-Week Range28% of range
Low
$3.78
Current
$6.96
High
$15.10